Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication.

Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI.

J Virol. 2006 May;80(10):5074-7. Erratum in: J Virol. 2006 Jul;80(13):6720.

2.

Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes.

Hel Z, Tsai WP, Tryniszewska E, Nacsa J, Markham PD, Lewis MG, Pavlakis GN, Felber BK, Tartaglia J, Franchini G.

J Immunol. 2006 Jan 1;176(1):85-96.

3.

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW.

J Virol. 2005 Dec;79(24):15547-55.

4.

Correlates of delayed disease progression in HIV-1-infected Kenyan children.

Chakraborty R, Morel AS, Sutton JK, Appay V, Ripley RM, Dong T, Rostron T, Ogola S, Palakudy T, Musoke R, D'Agostino A, Ritter M, Rowland-Jones SL.

J Immunol. 2005 Jun 15;174(12):8191-9.

5.

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC.

J Infect Dis. 2005 May 1;191(9):1403-9. Epub 2005 Mar 30.

PMID:
15809897
6.

Amplified HIV transmission and new approaches to HIV prevention.

Cohen MS, Pilcher CD.

J Infect Dis. 2005 May 1;191(9):1391-3. Epub 2005 Mar 30. No abstract available.

PMID:
15809893
7.

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M.

Nature. 2005 Apr 28;434(7037):1093-7.

PMID:
15793563
8.

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT.

Nature. 2005 Apr 28;434(7037):1148-52.

PMID:
15793562
9.

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.

Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M.

J Immunol. 2005 Feb 15;174(4):2185-9.

10.

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.

Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, Gurwith M, Heyward WL, Jobes DV, Popovic V, Self SG, Sinangil F, Burke D, Berman PW.

J Infect Dis. 2005 Mar 1;191(5):666-77. Epub 2005 Jan 27.

PMID:
15688279
11.
12.

Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Johnson PR, Schnepp BC, Connell MJ, Rohne D, Robinson S, Krivulka GR, Lord CI, Zinn R, Montefiori DC, Letvin NL, Clark KR.

J Virol. 2005 Jan;79(2):955-65.

13.

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

Picker LJ, Hagen SI, Lum R, Reed-Inderbitzin EF, Daly LM, Sylwester AW, Walker JM, Siess DC, Piatak M Jr, Wang C, Allison DB, Maino VC, Lifson JD, Kodama T, Axthelm MK.

J Exp Med. 2004 Nov 15;200(10):1299-314.

14.

Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.

Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, Napoé G, Mothé BR, O'Connor DH, Wilson NA, Watkins DI, Sette A.

J Immunol. 2004 Oct 15;173(8):5064-76.

15.

Deliberate removal of T cell help improves virus-neutralizing antibody production.

Recher M, Lang KS, Hunziker L, Freigang S, Eschli B, Harris NL, Navarini A, Senn BM, Fink K, Lötscher M, Hangartner L, Zellweger R, Hersberger M, Theocharides A, Hengartner H, Zinkernagel RM.

Nat Immunol. 2004 Sep;5(9):934-42. Epub 2004 Aug 8.

PMID:
15300247
16.

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Matano T, Kobayashi M, Igarashi H, Takeda A, Nakamura H, Kano M, Sugimoto C, Mori K, Iida A, Hirata T, Hasegawa M, Yuasa T, Miyazawa M, Takahashi Y, Yasunami M, Kimura A, O'Connor DH, Watkins DI, Nagai Y.

J Exp Med. 2004 Jun 21;199(12):1709-18.

17.

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS; Quest Study.; Duke-UNC-Emory Acute HIV Consortium..

J Infect Dis. 2004 May 15;189(10):1785-92. Epub 2004 Apr 28.

PMID:
15122514
19.

HIV vaccine design and the neutralizing antibody problem.

Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT.

Nat Immunol. 2004 Mar;5(3):233-6. No abstract available.

PMID:
14985706
20.

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M.

J Virol. 2004 Mar;78(5):2212-21.

Supplemental Content

Support Center